Investor George Armoyan has taken a 10% stake in Knight Therapeutics, a company in which Medici has been invested for several years.
 
What should we think about it?
 
Portfolio managers Pierre-Olivier Langevin and Yannick Clérouin talk about the stock’s prospects in our 68th webcast.
 
Watch the video.